Patent BG-3573-U1 (BG)
Title: Biologically active product
Inventor: DENKOVA ZAPRYANA
IPC: A23C9/123
Filed: 2019-11-14
Abstract: The utility model relates to a biologically active product for the needs of therapeutic, prophylactic and functional nutrition, as well as in chronic disorders resulting from malnutrition or lack of certain nutrients in the body, based on a symbiotic association of probiotic microorganisms derived from a targeted selection and registered in the NBIMCC. The quality and properties of the microbial association allow the creation of a biologically active product in different embodiments, namely: 1. Biologically active product, comprising (in wt. %): - Symbiotic association of probiotic strains of Lactobacillus delbrueckii subsp. bulgaricus LBG-MZ, NBIMCC 3600; Lactobacillus plantarum, NBIMCC 8811 and Lactobacillus acidophilus LAB 8, NBIMCC 2416 in a ratio of 1:1:2, respectively - from 87.0 to 90.0; - Prebiotic selected from the group consisting of fructans with 7 to 12 ? (1-> 2) -fructofuranose residues, palatinose and inulin - from 1.0 to 2.0; - Microcrystalline cellulose, magnesium silicate and magnesium stearate in a ratio of 10:0.5:0.5 - from 0.8 to 11.0. 2. Biologically active product, comprising (in wt. %): - Symbiotic association of probiotic strains of Lactobacillus delbrueckii subsp. bulgaricus LBG-MZ, NBIMCC 3600, Lactobacillus plantarum 15-226, NBIMCC 2415; Lactobacillus acidophilus LAB 8, NBIMCC 2416, Lactobacillus casei LHC 28, NBIMCC 3364 and Prorpionibacterium freudenreichii subsp. shermanii M 25, NBIMCC 327 in a ratio of 1:0.5:1:0.5:1, respectively from 87.0 to 90.0; - Prebiotic selected from the group consisting of fructans with 7 to 12 ? (1-> 2) -fructofuranose residues, palatinose and inulin - from 1.0 to 2.0; - Microcrystalline cellulose, magnesium silicate and magnesium stearate in a ratio of 10:0.5:0.5 - from 0.8 to 11.0. 3. Biologically active product, comprising (in wt. %): - Symbiotic association of probiotic strains of Lactobacillus delbrueckii subsp. bulgaricus LB 51-157, NBIMCC 3598; Lactobacillus plantarum, NBIMCC 8811; Lactobacillus acidophilus LAB 8, NBIMCC 2416; Lactobacillus fermentum, NBIMCC 8695 and Bifidobacterium bifidum BB-87, NBIMCC 3601 in a ratio of 1:0.5:1:0.5: 2, respectively from 87.0 to 90.0; - Prebiotic selected from the group consisting of fructans with 7 to 12 ? (1-> 2) -fructofuranose residues, palatinose and inulin - from 0.5 to 2.0; - Microcrystalline cellulose, magnesium silicate and magnesium stearate in a ratio of 10:0.5:0.5 - from 0.8 to 11.0. 4. Biologically active product, comprising (in wt. %) : - Symbiotic association of probiotic strains of Lactobacillus delbrueckii subsp. bulgaricus LBG-MZ, NBIMCC 3600; Lactobacillus acidophilus LAB 8, NBIMCC 2416; Lactobacillus casei LHC 28, NBIMCC 3364, Lactobacillus paracasei, NBIMCC 8805, Lactobacillus plantarum 15-226, NBIMCC 2415, Prorpionibacterium freudenreichii subsp. shermanii 582 D, NBIMCC 328 and Bifidobacterium bifidum BB-87, NBIMCC 3601 in a ratio of 1: 1: 0.5: 0.5: 0.5: 1: 2, respectively from 87.0 to 90.0; - Prebiotic selected from the group consisting of fructans with 7 to 12 ? (1-> 2) -fructofuranose residues, palatinose and inulin - from 1.0 to 2.0; - Microcrystalline cellulose, magnesium silicate and magnesium stearate in a ratio of 10: 0.5: 0.5 - from 0.8 to 11.0.